Sponsor or institution

Clinical trials and research at Phrontline Biopharma

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• TJ102 in advanced ovarian cancer and other solid tumors

  This trial tests TJ102, an experimental antibody-drug conjugate, in adults with advanced ovarian cancer or other solid tumors who have exhausted standard treatments to see if it is safe and may help shrink tumors.

  Recruiting Phase 1/2 Phrontline Biopharma · Los Angeles, California and 8 other locations · NCT07778498

• TJ101 for adults with advanced or metastatic solid tumors: finding a safe dose and checking for tumor response

  This trial tests TJ101, an experimental antibody‑drug given by IV, to see if it is safe and can shrink tumors in adults with advanced or metastatic solid cancers who have run out of standard treatment options.

  Recruiting at 4 sites Phase 1 Phrontline Biopharma · Orlando, Florida and 6 other locations · NCT07181473

Quick answers

How many clinical trials run by Phrontline Biopharma are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (2 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →